These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 20024839

  • 21. European Society of Cardiology--2009 annual congress. 31 August - 2 September 2009, Barcelona, Spain.
    Wong NC.
    IDrugs; 2009 Nov; 12(11):675-8. PubMed ID: 19844849
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. American Association for Cancer Research--100th Annual Meeting. New therapeutic developments: part 2. 18-22 April 2009, Denver, CO, USA.
    Gale S, McGee V, Lee W.
    IDrugs; 2009 Jun; 12(6):335-8. PubMed ID: 19517309
    [No Abstract] [Full Text] [Related]

  • 24. American Association for Cancer Research--100th Annual Meeting. New therapeutic developments: part 1. 18-22 April 2009, Denver, CO, USA.
    Gale S, McGee V, Lee W.
    IDrugs; 2009 Jun; 12(6):331-4. PubMed ID: 19517308
    [No Abstract] [Full Text] [Related]

  • 25. RNAi for Developing Targeted Therapeutics--CHI's Third Annual Meeting.
    Plane G.
    IDrugs; 2010 Jan; 13(1):20-2. PubMed ID: 20024842
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Phosphatases as targets for cancer treatment.
    Lazo JS, Wipf P.
    Curr Opin Investig Drugs; 2009 Dec; 10(12):1297-304. PubMed ID: 19943201
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Society for Neuroscience - 39th Annual Meeting. Part 2 - Novel therapies for neurodegenerative disorders and other CNS diseases.
    Al-Shamahi A, Kirkham K, Hookes L.
    IDrugs; 2009 Dec; 12(12):734-7. PubMed ID: 19943211
    [Abstract] [Full Text] [Related]

  • 35. Promising new agents under development by the Division of Cancer Treatment, Diagnosis, and Centers of the National Cancer Institute.
    Christian MC, Pluda JM, Ho PT, Arbuck SG, Murgo AJ, Sausville EA.
    Semin Oncol; 1997 Apr; 24(2):219-40. PubMed ID: 9129691
    [Abstract] [Full Text] [Related]

  • 36. Medicinal Chemistry - XXIst International Symposium.
    Chan D.
    IDrugs; 2010 Nov; 13(11):749-52. PubMed ID: 21046517
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Molecular targets and cancer therapeutics: discovery, development and clinical validation.
    Teicher BA.
    Drug Resist Updat; 2000 Apr; 3(2):67-73. PubMed ID: 11498368
    [Abstract] [Full Text] [Related]

  • 39. Metastasis and the Tumor Microenvironment: A Joint Metastasis Research Society-AACR Conference - Research on Metastasis: part 2.
    Eccles SA.
    IDrugs; 2010 Nov; 13(11):768-71. PubMed ID: 21046523
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.